CTCBio Overview
- Year Founded
-
1993
- Status
-
Public
- Employees
-
254
- Stock Symbol
-
060590
- Investments
-
2
- Share Price
-
$2.08
- (As of Friday Closing)
CTCBio General Information
Description
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.
Contact Information
Website
www.ctcbio.comCorporate Office
- 509, 12th floor, Dosan-daero
- Gangnam-gu, Cheongdam-dong
- Seoul, Gyeonggi-do
- South Korea
Corporate Office
- 509, 12th floor, Dosan-daero
- Gangnam-gu, Cheongdam-dong
- Seoul, Gyeonggi-do
- South Korea
CTCBio Timeline
CTCBio Stock Performance
As of 13-Nov-2026, CTCBio’s stock price is $2.08. Its current market cap is $49.6M with 23.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.08 | $1.99 | $1.73 - $3.82 | $49.6M | 23.9M | 38.8K | $0.22 |
CTCBio Financials Summary
As of 30-Jun-2026, CTCBio has a trailing 12-month revenue of $90.6M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 58,175 | 88,213 | 115,493 | 205,102 |
| Revenue | 90,638 | 86,969 | 87,858 | 105,456 |
| EBITDA | 11,793 | 8,095 | 2,142 | (5,541) |
| Net Income | 5,177 | 2,277 | (3,826) | (11,922) |
| Total Assets | 97,356 | 99,468 | 104,339 | 128,707 |
| Total Debt | 26,139 | 26,905 | 22,315 | 27,384 |
CTCBio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CTCBio Patents
CTCBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260263361-A1 | Cannabidiol aqueous solution composition and cannabidiol-containing pharmaceutical preparation comprising same | Pending | 17-Mar-2023 | ||
| WO-2024196096-A1 | Cannabidiol aqueous solution composition and cannabidiol-containing pharmaceutical preparation comprising same | Inactive | 17-Mar-2023 | ||
| WO-2024136615-A1 | Lactobacillus having prophylactic or therapeutic activity for colitis disease and antibacterial activity against harmful gut bacteria and use thereof | Inactive | 23-Dec-2022 | ||
| WO-2023080764-A1 | Lactic acid bacteria having antibacterial activity against microorganisms causing vaginosis or urinary tract infection and use thereof | Inactive | 08-Nov-2021 | ||
| CA-3150011-A1 | Intraoral fast disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation | Pending | 09-Aug-2019 | A61K36/3482 |
CTCBio Signals
CTCBio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CTCBio Investments & Acquisitions (2)
CTCBio’s most recent deal was a Corporate Asset Purchase with SK Chemical (Ansan Plant). The deal was made on 01-Sep-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SK Chemical (Ansan Plant) | 01-Sep-2014 | Corporate Asset Purchase | Buildings and Property | ||
| LG Life Sciences (Animal Drug Business) | 01-Apr-2007 | Merger/Acquisition | Other Agriculture |
CTCBio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
CTCBio FAQs
-
When was CTCBio founded?
CTCBio was founded in 1993.
-
Where is CTCBio headquartered?
CTCBio is headquartered in Seoul, South Korea.
-
What is the size of CTCBio?
CTCBio has 254 total employees.
-
What industry is CTCBio in?
CTCBio’s primary industry is Pharmaceuticals.
-
Is CTCBio a private or public company?
CTCBio is a Public company.
-
What is CTCBio’s stock symbol?
The ticker symbol for CTCBio is 060590.
-
What is the current stock price of CTCBio?
As of 13-Nov-2026 the stock price of CTCBio is $2.08.
-
What is the current market cap of CTCBio?
The current market capitalization of CTCBio is $49.6M.
-
What is CTCBio’s current revenue?
The trailing twelve month revenue for CTCBio is $90.6M.
-
What is CTCBio’s annual earnings per share (EPS)?
CTCBio’s EPS for 12 months was $0.22.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process